MESULID Gel 3.0 %w/w आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

mesulid gel 3.0 %w/w

helsinn birex therapeutics ltd - nimesulide - gel - 3.0 %w/w

Warfarin Teva 0.5mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfarin teva 0.5mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 0.5 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extensiona and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 1 mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfarin teva 1 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 1 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 2 mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfarin teva 2 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 2 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 2.5 mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfarin teva 2.5 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 2.5 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 10 mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfarin teva 10 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 10 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 7.5 mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfarin teva 7.5 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 7.5 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 6 mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfarin teva 6 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 6 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 5 mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfarin teva 5 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 5 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 3 mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

warfarin teva 3 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 3 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.